Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines. [electronic resource]
Producer: 20080819Description: 456-67 p. digitalISSN:- 1590-8577
- Amylases -- blood
- Animals
- Cholangiopancreatography, Endoscopic Retrograde -- adverse effects
- Disease Models, Animal
- Dogs
- Etanercept
- Immunoglobulin G -- therapeutic use
- Lipase -- blood
- Oligopeptides -- urine
- Pancreas -- pathology
- Pancreatitis -- blood
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Failure
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.